Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2023-10-13
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary study procedures include: chart abstraction, questionnaires, meetings with ICU support counselors, meetings with ICU physicians and care team, audio recordings of these meetings (optional), and interviews with study participants (optional).
Study participants include: 70 critically ill patients with acute respiratory failure (enrolled with the consent of their Legally Authorized Representative) and their primary surrogate decision makers as well as ICU support counselors and ICU care teams (physicians, nurses, social workers).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Family Support Intervention in Intensive Care Units (The Four Supports Study)
NCT01107704
The Family Cares Trial
NCT06984770
Meaning-Centered Psychotherapy Training for Cancer Care Providers
NCT02730039
Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer
NCT03049397
Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
NCT00580515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Family Perspective Program
Families of critically ill patients will receive a program designed to enhance equitable communication and emotional support.
Questionnaires will be completed by primary surrogate decision makers, ICU support counselors, and ICU care team members (physicians, nurses, social workers). Meetings between families and ICU support counselors will be audio recorded (optional). Meetings between families and ICU care teams will be audio recorded (optional). Interviews with participants will be completed (optional).
Family Perspective Program
The program involves regular meetings between families and an ICU support counselor. The ICU support counselor is a trained expert in providing culturally competent emotional and/or spiritual support. The ICU support counselor will support families and also learn and summarize family perspectives in a standardized report. ICU care team members will be prompted to perspective take as they review reports prior to regular routine meetings between families and the ICU care team.
Usual Care
Families of critically ill patients will receive usual care, which involves regular and routine meetings between families and the ICU care team.
Questionnaires will be completed by primary surrogate decision makers and ICU care team members (physicians, nurses, social workers). Meetings between families and ICU care teams will be audio recorded (optional). Interviews with participants will be completed (optional).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family Perspective Program
The program involves regular meetings between families and an ICU support counselor. The ICU support counselor is a trained expert in providing culturally competent emotional and/or spiritual support. The ICU support counselor will support families and also learn and summarize family perspectives in a standardized report. ICU care team members will be prompted to perspective take as they review reports prior to regular routine meetings between families and the ICU care team.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals admitted to the medical intensive care unit (MICU) at Cedars-Sinai Medical Center.
* Individuals with acute respiratory failure, defined as \>24 hours of invasive mechanical ventilation.
* Individuals who received invasive mechanical ventilation within 24 hours of admission to the MICU.
* Individuals expected to need invasive mechanical ventilation for \>72 hours total, as determined by the patient's intensivist physician (fellow or attending).
o Individuals 18 years old or older.
* Individual who self-identifies as the most responsible for making decisions for the enrolled patient (can be either family member or close friend).
* Proficiency in English language.
* Individuals 18 years old or older.
* Individuals who work as hospital chaplains in the MICU.
* Individuals 18 years old or older.
* Individuals who work as critical care physicians in the MICU (fellow or attending).
* Individuals 18 years old or older.
* Individuals who work as bedside nurses in the MICU.
* Individuals 18 years old or older.
* Individuals work as social workers in the MICU.
Exclusion Criteria
o Individuals expected to die within 24 hours of potential enrollment, as determined by the patient's intensivist physician (fellow or attending).
o Individuals on comfort care protocol or with clear preference for comfort care, as determined by the patient's intensivist physician (fellow or attending).
* Individuals who are chronically dependent on a ventilator prior to admission.
* Individuals with acute on chronic neuromuscular disease-related respiratory failure (e.g., Guillain Barre, Muscular Dystrophy, Myasthenia Gravis, etc.).
* Individuals imminently awaiting organ transplant, as determined by the patient's intensivist physician (fellow or attending).
* Individuals with decisional capacity, as determined by the patient's intensivist physician (fellow or attending).
* Individuals who are unrepresented (i.e., patient has no surrogate decision maker).
* Individuals whose potential enrolled family member (primary surrogate decision maker) is not proficient in English.
* Individuals whose attending physician is the PI on this study at the time of potential enrollment.
* Individuals who are cared for by intensivist physicians (fellow and attending) who do not agree to participate in the study.
* Individuals who have a pre-existing relationship with a hospital chaplain who does not agree to participate in the study, as determined by that chaplain.
o Not proficient in English language. (Rationale: materials and intervention are not adapted in other languages.)
o None
o None
o None
* None
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Palliative Care Research Center
OTHER
Matthew Modes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew Modes
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Modes, MD, MPP, MS
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars-Sinai Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Study00002813
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.